JAK2 and myeloproliferative neoplasm: Transplant, transgenic and conditional knock-in murine models have shown that expression of mutated JAK2V617F is sufficient to recapitulate a MPN phenotype [11]–[19], indicating that constitutive activation of the JAK2/STAT pathway deserves a central role in the pathogenesis of MPNs.